Why alarm is easing over a rise in pancreatic cancer among the young

by Robin FosterExperts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any increase in deaths from the

Updated on: December 02,2024

Why alarm is easing over a rise in pancreatic cancer among the young

by Robin FosterExperts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any increase in deaths from the

Updated on:December 02,2024

New study seeks hereditary causes of childhood cancer

byKarolinska InstitutetOverview of study design and study cohort. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.100881Follow-up and treatment of children

Updated on: April 28,2024

New study seeks hereditary causes of childhood cancer

byKarolinska InstitutetOverview of study design and study cohort. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.100881Follow-up and treatment of children

Updated on:April 28,2024

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli

Updated on: December 22,2023

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli

Updated on:December 22,2023

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6

Updated on: May 26,2024

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6

Updated on:May 26,2024

How dangerous is it for lung cancer patients to skip radiation treatments?

by Cara MurezAs doctors work toward developing more personalized cancer care, a new study looks at whether lung cancer patients can miss a few days of radiation treatment and make them up with a highe

Updated on: December 22,2023

How dangerous is it for lung cancer patients to skip radiation treatments?

by Cara MurezAs doctors work toward developing more personalized cancer care, a new study looks at whether lung cancer patients can miss a few days of radiation treatment and make them up with a highe

Updated on:December 22,2023

Healthy habits could prevent 27% of cancer cases in Brazil

by Maria Fernanda Ziegler,FAPESPA study by Brazilian researchers in partnership with Harvard estimates the impact of five risk factors on the incidence of cancer- physical inactivity, unhealthy

Updated on: May 05,2024

Healthy habits could prevent 27% of cancer cases in Brazil

by Maria Fernanda Ziegler,FAPESPA study by Brazilian researchers in partnership with Harvard estimates the impact of five risk factors on the incidence of cancer- physical inactivity, unhealthy

Updated on:May 05,2024

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on: December 22,2023

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on:December 22,2023

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m

Updated on: October 24,2023

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m

Updated on:October 24,2023

Stage and receptor status can indicate a breast cancer survivor's risk of recurrence

Updated on: December 22,2023

Stage and receptor status can indicate a breast cancer survivor's risk of recurrence

Updated on:December 22,2023

Study suggests new strategy for treating advanced, progressing bile duct cancer

byOhio State University Medical CenterCredit: Ohio State University Medical CenterA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer H

Updated on: December 22,2023

Study suggests new strategy for treating advanced, progressing bile duct cancer

byOhio State University Medical CenterCredit: Ohio State University Medical CenterA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer H

Updated on:December 22,2023

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo

Updated on: May 26,2024

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo

Updated on:May 26,2024

Prozac fights deadly childhood brain cancer

by Hayley Jarvis,Brunel UniversityKiller T cells surround a cancer cell. Credit: NIHThe anti-depressant drug Prozac could be used to tackle one of the deadliest childhood tumours and possibly ot

Updated on: December 22,2023

Prozac fights deadly childhood brain cancer

by Hayley Jarvis,Brunel UniversityKiller T cells surround a cancer cell. Credit: NIHThe anti-depressant drug Prozac could be used to tackle one of the deadliest childhood tumours and possibly ot

Updated on:December 22,2023